SEC Tracker
Get the app

Adm Tronics Unlimited ADMT

Adm Tronics Unlimited Q2 FY24: net loss $53K

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Adm Tronics Unlimited reported for Q2 FY24, the quarter ended Sep 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income−$53KAgainst −$228K in Q2 FY2310-Q income statement, on EDGAR
  2. Cash and cash equivalents$428K−40% from $716K in Q2 FY2310-Q balance sheet, on EDGAR
  3. Cash from operations−$379KAgainst −$203K in Q2 FY2310-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Adm Tronics Unlimited files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

  1. Sonoma Pharmaceuticals SNOA public float $6M, Sep 30, 2025
  2. Bone Biologics BBLG public float $7M, Jun 30, 2025
  3. Autonomix Medical AMIX public float $6M, Sep 30, 2025
  4. ENvue Medical FEED public float $7M, Jun 30, 2025
  5. SeaStar Medical Holding ICU public float $7M, Jun 30, 2025